Chemical Structure : GNE-900
CAS No.: 1200126-26-6
货号: PC-60310Not For Human Use, Lab Use Only.
GNE-900 (GNE900) is a potent, selective, ATP-competitive, and orally bioavailable Chk1 inhibitor with IC50 of <1 nM.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
5 mg | ¥1880 | In stock | |
10 mg | ¥3180 | In stock | |
25 mg | ¥5280 | In stock | |
50 mg | Get quote | ||
100 mg | Get quote |
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
GNE-900 (GNE900) is a potent, selective, ATP-competitive, and orally bioavailable Chk1 inhibitor with IC50 of <1 nM.
GNE-900 displays >300-fold selectivity over Aurora, PLK, CDK1/2) and ChK2.
GNE-900 abrogates DNA damage-induced S and G2–M checkpoints (EC50=61.8 nM in H-29 cells), and exacerbates DNA double-strand breaks (DSB) to induce cell death, accelerates the demise of damaged HCT-116 colorectal cancer cells in a p53-dependent manner in vitro.
GNE-900 potentiates the efficacy of gemcitabine in tumor xenografts.
分子量 | 367.45 | |
分子式 | C23H21N5 | |
外观性状 | Solid | |
储存条件 |
|
|
Solubility |
10 mM in DMSO |
|
Chemical Name/SMILES |
3-(4-(piperidin-1-ylmethyl)phenyl)-9H-pyrrolo[2,3-b:5,4-c']dipyridine-6-carbonitrile |
1. Blackwood E, et al. Mol Cancer Ther. 2013 Oct;12(10):1968-80.
2. Xiao Y, et al. Mol Cancer Ther. 2013 Nov;12(11):2285-95.
3. Gazzard L, et al. J Med Chem. 2015 Jun 25;58(12):5053-74.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright